ClavystBio — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
65LAB65lab.sgOct 2023
A drug discovery and therapeutic company creation platform that accelerates the development of new medicines from research institutions in Singapore.
BiotechDeep TechSingapore, SG
Co-investorsLightstone VenturesLeaps by Bayer
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.